Lipoproteins, Vascular-Related Genetic Factors, and Human Longevity
- 1 December 2007
- journal article
- review article
- Published by Mary Ann Liebert Inc in Rejuvenation Research
- Vol. 10 (4) , 441-458
- https://doi.org/10.1089/rej.2007.0537
Abstract
The relationships among lipoprotein metabolism, genetic vascular factors, vascular disease, and Alzheimer's disease suggest that the examination of centenarian populations in relation to certain genes or lipoprotein metabolism provide insights into human longevity. The findings on the higher frequency of the apolipoprotein E ɛ4 allele in middle-aged subjects than in centenarians were substantially confirmed. On the contrary, recent findings did not confirm previous data on increased prevalence of the high-risk angiotensin I converting enzyme D allele in French centenarians. The variability in the strength of association between angiotensin I converting enzyme polymorphism and longevity could be related to regional differences in angiotensin I converting enzyme D allele frequency in Europe recently showed, as also recently reported for apolipoprotein Eɛ2 and ɛ4 allele in centenarians. Indeed some studies of lipoprotein profiles in centenarians have also had contradictory outcomes, with evidence of lower serum levels of high-density lipoprotein cholesterol, with higher high-density lipoprotein 2 cholesterol subfraction, larger high-density lipoprotein and low-density lipoprotein particle sizes, and higher lipoprotein(a) concentration in centenarians, which is apparently disadvantageous for human longevity. Elevated lipoprotein(a) serum levels, increasing the risk for cerebrovascular disease, may play a role in determining clinical Alzheimer's disease, but lipoprotein(a) elevation in centenarians, in the absence of other coronary artery disease risk factors, appears as a positive survival factor. In different populations, there are significant trends in the reduction of serum apolipoprotein E levels from apolipoprotein E ɛ2- to ɛ4-carriers and significant differences in serum apolipoprotein E levels with respect to age in ɛ4-carriers but only after adjustment for high-density lipoprotein cholesterol. While further studies are needed to confirm the possible role of apolipoprotein E concentration as putative longevity factor this paper provides an overview of many of the investigated vascular factors with respect to longevity.Keywords
This publication has 103 references indexed in Scilit:
- Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseNature Genetics, 2007
- Lipoprotein Particle Profiles Mark Familial and Sporadic Human LongevityPLoS Medicine, 2006
- ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old AgePLoS Medicine, 2006
- Lipoprotein Genotype and Conserved Pathway for Exceptional Longevity in HumansPLoS Biology, 2006
- Candidate genes associated with ageing and life expectancy in the Jerusalem longitudinal studyMechanisms of Ageing and Development, 2005
- Mortality differences by APOE genotype estimated from demographic synthesisGenetic Epidemiology, 2002
- Decreased frequency of apolipoprotein E ε4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenariansNeuroscience Letters, 1999
- Genetic associations with human longevity at the APOE and ACE lociNature Genetics, 1994
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990
- Apolipoprotein E polymorphism in the Netherlands and its effect on plasma lipid and apolipoprotein levelsHuman Genetics, 1988